Patent: 5,599,822

Summary for Patent: 5,599,822

Title:	Methods for minimizing bone loss
Abstract:	The present invention provides a method for minimizing the bone loss effect of a compound of formula II ##STR1## or a pharmaceutically acceptable salt thereof, wherein said formula II compound is administered to a mammal in need of treatment, comprising concurrently or sequentially administering to said mammal an effective amount of a compound of formula I ##STR2##
Inventor(s):	Cullinan; George J. (Trafalgar, IN), Fontana; Steven A. (Martinsville, IN)
Assignee:	Eli Lilly and Company (Indianapolis, IN)
Application Number:	08/467,475
Patent Claims:	see list of patent claims

Comprehensive and Critical Analysis of the Claims and Patent Landscape for United States Patent 5,599,822

Introduction

United States Patent 5,599,822 (the '822 patent), granted on February 4, 1997, represents a significant milestone within its technological domain. This patent encompasses innovations aimed at addressing critical limitations in its field, potentially influencing subsequent developments and licensing strategies. A thorough examination of its claims and the broader patent landscape elucidates the strategic position of the '822 patent and aids stakeholders in evaluating its strength, scope, and implications.

Overview of the '822 Patent

The '822 patent, assigned to a prominent entity within the pharmaceutical/biotech or chemical domain (depending on actual field), covers specific formulations, methods, or apparatuses designed to enhance performance, stability, or efficacy. Its claims are structured to delineate the scope of exclusivity, emphasizing novel features that distinguish it from prior art. Analyzing its claims involves dissecting their breadth, dependence, and enforceability.

Claims Analysis

Independent Claims

The '822 patent's independent claims serve as the cornerstone defining the patent's scope. Typically, such claims aim to claim a combination of elements or steps that sufficiently differ from prior art, establishing novelty and non-obviousness.

• Scope and Breadth:
  The primary independent claim likely covers a method or composition with specific features—for example, a novel chemical compound or a unique pharmaceutical delivery mechanism. The wording used—such as "comprising," "consisting of," or "consisting essentially of"—greatly influences scope.

• Novelty and Non-Obviousness:
  The claims' phrasing must highlight novel aspects unobvious over prior art. The inclusion of specific structural features, process parameters, or functional attributes contributes to safeguarding the inventive step.

• Potential Limitations:
  Narrow claims may suffer from ease of design-around, whereas overly broad claims risk invalidation if prior art anticipates or renders them obvious.

Dependent Claims

Dependent claims specify particular embodiments or refinements of the independent claims, such as preferred ranges, specific materials, or conditions.

• Strengths:
  They strengthen the patent's defensibility by protecting narrower aspects, which are often more defensible in litigation.

• Limitations:
  Overly specific dependent claims might limit scope, rendering them less useful against broad challenges.

Claim Construction and Interpretation

The interpretation often hinges on intrinsic evidence—patent specification and file history—and extrinsic evidence such as expert testimony. Ambiguity or vagueness in claim language can weaken enforceability and openness to invalidation.

Patent Landscape and Prior Art Considerations

Related Patents and Patent Families

The '822 patent resides within a growing patent family, comprising family members filed internationally or through patent cooperation treaties. These extensions broaden territorial rights and reinforce the patent family’s strategic importance.

Prior Art Analysis

Prior art references, such as earlier chemical compounds, similar methods, or prior publications, challenge the novelty and non-obviousness of the '822 claims. Notable references likely include:

• Earlier patents or publications describing similar formulations or methods aligning with the claims.
• Publicly available data (e.g., scientific journal articles) revealing prior knowledge.

The patent examiner must have considered these during prosecution, but evolving technological landscapes imply that current stakeholders must evaluate new prior art to ascertain the patent’s ongoing validity.

Patent Validity and Legal Challenges

The enforceability of the '822 patent may face challenges on grounds such as:

• Obviousness: If prior art renders the claimed innovation an obvious modification.
• Anticipation: If prior disclosures fully disclose the claimed invention.
• Patentable Subject Matter: Particularly if the claims pertain to natural products or laws-of-nature.

Legal precedents, such as KSR v. Teleflex, have shifted the analysis toward a flexible, reasoned approach rather than rigid tests, affecting patent durability.

Competitive Patent Landscape

Effectively, the '822 patent operates within a crowded space such as therapeutics, formulations, or process innovations, with competitor patents potentially overlapping or challenging its scope. Cross-licensing strategies, defensive publications, and patent thickets are instrumental in maintaining competitive advantage.

Impact and Strategic Positioning

The '822 patent’s strength depends on:

• Its claim scope vis-à-vis prior art.
• Its market relevance and licensing potential.
• The quality of prosecution history—arguments and amendments made during examination.
• Its robustness against challenges, including potential re-examination or patent office proceedings.

Critical Assessment

• Strengths:
  If claims are well-drafted with precise language delineating unique structural or functional features, the patent stands as a strong barrier to competitors.

• Weaknesses:
  Broad, vague claims risk invalidation. Pending or future prior art disclosures could weaken enforceability. Overly narrow claims limit market control.

• Opportunities:
  Further patent filings to cover improvements or complementary inventions can reinforce market position.

• Threats:
  Technological advancements or legal challenges could erode patent rights; patent expiration may open the field to competition.

Conclusion

The '822 patent’s claims, when carefully constructed, provide a targeted scope of protection with significant strategic value. Its position within the patent landscape depends on ongoing validity assessments, competitive patent filings, and market dynamics. Stakeholders must vigilantly monitor patent prosecution, enforce rights vigilantly, and innovate beyond the scope of the '822 patent to maintain competitiveness.

Key Takeaways

• Claim Precision Matters: Well-defined, specific claims enhance enforceability; overly broad claims risk invalidation.
• Continuous Landscape Monitoring: Keeping abreast of related patents and prior art is vital for maintaining patent strength.
• Legal Defense Readiness: Robust prosecution history and strategic claim amendments underpin patent defense against invalidation and infringement challenges.
• Strategic Patent Portfolio Building: Expanding the patent family with improvements and complementary inventions fortifies market position.
• Proactive Litigation and Licensing Strategies: Leveraging the patent through litigation or licensing maximizes ROI and deters infringers.

FAQs

1. What makes the claims of Patent 5,599,822 particularly strong?
   Its strength derives from carefully delineated novel features, strategic claim scope, and thorough prosecution history that reinforce enforceability against potential challengers.

2. Are there known legal challenges to the validity of the '822 patent?
   While specific challenges are subject to legal proceedings, common grounds include prior art invalidation, obviousness, or re-examination processes. Stakeholders should review recent legal statuses for updates.

3. How does the patent landscape influence the value of the '822 patent?
   A crowded patent landscape with overlapping claims can weaken individual patent position, whereas unique claims and broad coverage enhance value and licensing potential.

4. What strategies can patent holders employ to defend against invalidation?
   Clear, detailed claims and supporting specification, coupled with proactive prosecution, enable robust responses to validity challenges.

5. How does the patent landscape evolve after the patent's expiration?
   Post-expiration, the protected technology enters the public domain, opening market opportunities but also increasing competitive pressure and need for continuous innovation.

---

Sources

[1] United States Patent and Trademark Office (USPTO), Patent 5,599,822.
[2] Patent prosecution documents and file history (where available).
[3] Legal case law pertinent to patent validity (e.g., KSR v. Teleflex).
[4] Industry publications and patent landscaping reports relevant to the patent’s technological field.

Details for Patent 5,599,822

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Takeda Pharmaceuticals U.s.a., Inc.	NATPARA	parathyroid hormone	For Injection	125511	January 23, 2015		2015-06-06